Clinical Trials Browser

Carcinoma, Hepatocellular × Neoadjuvant Therapy × 90 days × Clear all

NCT06045975 2026-04-24

DUMELEP

Phase 2 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular